Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Tianjin Hemay Pharmaceutical Co.,Ltd)"
Count: 16
Selected: 0
| NCT ID | Title |
|---|
| NCT02467569 | Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer | ||
| NCT05407246 | Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis | ||
| NCT05247216 | A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis | ||
| NCT04839328 | A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis | ||
| NCT04837235 | Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects | ||
| NCT04609397 | A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease | ||
| NCT04352595 | A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients | ||
| NCT04102241 | Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis | ||
| NCT04100642 | A Phase I Clinical Study of Hemay808 | ||
| NCT03977480 | Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis | ||
| NCT03308201 | Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer | ||
| NCT02476539 | Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer | ||
| NCT02603185 | PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers | ||
| NCT05122494 | A Phase Ⅲ Study of the Efficacy and Safety of Hemay022+Aromatase Inhibitor(AI) in Participants With ER+/HER2+ Advanced or Metastatic Breast Cancer | ||
| NCT04673474 | A Food-Effect Study of Hemay022 in Healthy Participants | ||
| NCT03982303 | Phase I Study of Hemay102 in Patients With Advanced Solid Tumors |
